ASIA News
The telemedicine platform will start by offering diabetes care support.
It looks to grow its engineering, product, and design teams while expanding across Asia.
The clearance represents what could be the world's first regulatory approval of a DTx app for hypertension treatment.
The company is looking to expand its coverage across China's Greater Bay Area.
The AI tech can spot signs of pancreatic cancer from non-contrast CT images.
It plans to develop an in-house cloud platform.
Its fresh funds will support its product development and international expansion efforts.
The company aims to help the self-testing market grow by licensing its core technology for transforming smartphones into IVD devices.
Its web-based platform also guides patients to access appropriate medical care.
It plans to expand its coverage in the domestic market.